Morgan Stanley Call 6.5 FMV 21.06.../ DE000MB3Q509 /
06/06/2024 10:28:02 | Diferencia+0.070 | Bid12:12:00 | Ask12:12:00 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.490EUR | +16.67% | 0.480 Volumen de oferta: 2,500 |
0.530 Tamaño/ Volumen/ Formato de Ask: 2,500 |
FIRST MAJESTIC SILVE... | 6.50 - | 21/06/2024 | Call |
GlobeNewswire
12:30
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
12:29
Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial ...
GlobeNewswire
12:00
Hooker Furnishings Reports First Quarter Operating Results and Cost Reduction Plan
GlobeNewswire
12:00
ResVR Announces Oversubscribed Financing Seed Round Of $1.7M CAD To Expand Visualization Software Fo...
GlobeNewswire
12:00
Brunswick Corporation named one of America’s Greatest Workplaces for Mental Wellbeing 2024 from News...
GlobeNewswire
12:00
Flash News: OKX Lists Ultiverse's Token on its Spot Market, Expanding Trading Options
GlobeNewswire
11:43
European Bioplastics elects new Board with Mariagiovanna Vetere and Franz Kraus elected as Co-Chairs
GlobeNewswire
11:00
QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2024
GlobeNewswire
11:00
Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinica...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página